世界の非血液がん治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04000)
◆英語タイトル:Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04000
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは非血液がん治療の世界市場について調査・分析した資料です。種類別(化学療法、手術、放射線療法、その他)の市場規模、用途別(病院、腫瘍治療センター、外来手術センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別非血液がん治療の競争状況、市場シェア
・世界の非血液がん治療市場:種類別市場規模 2015年-2020年(化学療法、手術、放射線療法、その他)
・世界の非血液がん治療市場:種類別市場規模予測 2021年-2026年(化学療法、手術、放射線療法、その他)
・世界の非血液がん治療市場:用途別市場規模 2015年-2020年(病院、腫瘍治療センター、外来手術センター、その他)
・世界の非血液がん治療市場:用途別市場規模予測 2021年-2026年(病院、腫瘍治療センター、外来手術センター、その他)
・北米の非血液がん治療市場分析:米国、カナダ
・ヨーロッパの非血液がん治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの非血液がん治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の非血液がん治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの非血液がん治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.
North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.

Market Analysis and Insights: Global Non-Hematological Cancer Treatment Market
The global Non-Hematological Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Non-Hematological Cancer Treatment Scope and Market Size
Non-Hematological Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Hematological Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma

Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation Therapy
Others
Market segment by Application, split into
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Hematological Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Non-Hematological Cancer Treatment Market Perspective (2015-2026)
2.2 Global Non-Hematological Cancer Treatment Growth Trends by Regions
2.2.1 Non-Hematological Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Hematological Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Non-Hematological Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-Hematological Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Hematological Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Non-Hematological Cancer Treatment Players by Market Size
3.1.1 Global Top Non-Hematological Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Hematological Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Hematological Cancer Treatment Market Concentration Ratio
3.2.1 Global Non-Hematological Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Hematological Cancer Treatment Revenue in 2019
3.3 Non-Hematological Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Non-Hematological Cancer Treatment Product Solution and Service
3.5 Date of Enter into Non-Hematological Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Non-Hematological Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Non-Hematological Cancer Treatment Market Size (2015-2020)
6.2 Non-Hematological Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Non-Hematological Cancer Treatment Market Size (2015-2020)
7.2 Non-Hematological Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Non-Hematological Cancer Treatment Market Size (2015-2020)
8.2 Non-Hematological Cancer Treatment Key Players in China (2019-2020)
8.3 China Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
8.4 China Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Non-Hematological Cancer Treatment Market Size (2015-2020)
9.2 Non-Hematological Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Non-Hematological Cancer Treatment Market Size (2015-2020)
10.2 Non-Hematological Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Non-Hematological Cancer Treatment Market Size (2015-2020)
11.2 Non-Hematological Cancer Treatment Key Players in India (2019-2020)
11.3 India Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
11.4 India Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Non-Hematological Cancer Treatment Market Size (2015-2020)
12.2 Non-Hematological Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Non-Hematological Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Non-Hematological Cancer Treatment Introduction
13.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Non-Hematological Cancer Treatment Introduction
13.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Non-Hematological Cancer Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Non-Hematological Cancer Treatment Introduction
13.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Non-Hematological Cancer Treatment Introduction
13.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Non-Hematological Cancer Treatment Introduction
13.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Astellas Pharma
13.7.1 Astellas Pharma Company Details
13.7.2 Astellas Pharma Business Overview
13.7.3 Astellas Pharma Non-Hematological Cancer Treatment Introduction
13.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.7.5 Astellas Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の非血液がん治療市場2026:インサイト・予測(Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。